Alopecia type and pattern
Patchy, diffuse, frontal, crown, temporal, scarring or mixed pattern is described with onset and speed of progression.
A structured dermatology review for alopecia and hair-loss conditions, organized around diagnosis type, scalp photos, progression, laboratory context, previous treatment history and realistic next-step planning.
Alopecia review should distinguish patchy alopecia areata, androgenetic hair loss, telogen effluvium, scarring alopecia, traction alopecia and mixed patterns. The physician needs photos, timeline, scalp symptoms, labs and prior treatment history to decide what can reasonably be reviewed and what must be evaluated locally.
Patchy, diffuse, frontal, crown, temporal, scarring or mixed pattern is described with onset and speed of progression.
Frontal, temporal, crown, part-line and affected patch photos help make the file visually useful.
Itching, burning, scaling, pain, redness, pustules or scarring signs may change urgency and review route.
Iron/ferritin, thyroid, vitamin D, hormonal tests, autoimmune context, recent illness or medication changes are reviewed when available.
Topical minoxidil, corticosteroids, injections, oral therapies, PRP, supplements or procedures are summarized with response.
The file should clarify whether the patient wants diagnosis review, therapy options, treatment context or realistic prognosis discussion.
The page is intentionally structured around clinical decision factors, not around promotional claims. The aim is to make the file safer, clearer and easier to review.
Hair loss is a sign, not one disease. Treatment discussion is weak if the alopecia type is not clear.
Pain, redness, scaling or scarring may require prompt local dermatology evaluation and sometimes biopsy.
Nutritional, thyroid, hormonal or autoimmune factors can affect review and expectations.
Hair-loss treatment timelines are often measured in months, so written expectations should be clear before treatment or travel logistics.
A hair-loss file should combine photos, timeline and medical context. This helps the physician avoid guessing from appearance alone.
The page does not present a procedure or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
The patient should continue appropriate local care while the file is being organized, especially when symptoms are active or worsening.
Treatment names may be part of the medical context, but suitability, contraindications, dosing and monitoring must be determined by physicians.
The first decision is whether the file is complete enough for a responsible written response. Logistics come only after clinical clarity.
In hair loss, the type of loss — not the product — determines treatment.
Products offered in Cuba for hair loss include the Piloactive lotion and shampoo, which contain human placenta-derived components. The reported effects are nourishment of the hair root, improved scalp circulation and support for protein formation in the follicle. Treating centres report high response rates; these are presented as centre-reported data, and the expectation in your case is discussed after dermatological assessment.
The right approach begins with a diagnosis. Alopecia areata is immune-mediated and appears as sudden loss in defined round patches; androgenetic alopecia is the gradual, patterned thinning seen in men and women; telogen effluvium is temporary diffuse shedding after fever, surgery, childbirth, severe stress, iron deficiency or thyroid disturbance. The treatment of these three is entirely different.
The file should therefore contain a dermatology examination note, dermoscopy findings and basic blood tests (full blood count, ferritin, TSH, vitamin D, and zinc or hormonal panels where indicated). In alopecia areata, current approaches include topical and intralesional corticosteroids, topical immunotherapy and, in extensive disease, JAK inhibitors; these should be assessed before any alternative is sought.
Decisions taken without separating alopecia areata, androgenetic alopecia and telogen effluvium are misleading.
Ferritin, TSH, full blood count and vitamin D reveal correctable causes and often make a difference on their own.
Because of the hair cycle, visible change with any treatment usually takes three to six months; earlier judgement misleads.
International coordination should never delay emergency or necessary local care. If any of the following are present, the patient should be assessed locally first.
No. It helps prepare the record. Diagnosis must be confirmed by licensed dermatology professionals.
Photos are useful but usually not enough. Timeline, symptoms, labs and previous treatments are also important.
No. Hair-loss treatment depends on alopecia type, medical background and physician assessment.
Pain, redness, scaling, pustules or scarring signs should be assessed locally first because they may require urgent dermatology care.
The team organizes the file, translations where needed, communication and written next-step logistics after review.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.